Tourmaline Bio Inc.

NASDAQ: TRML
Share price (3/25/25): $17.12
Market cap (3/25/25): $440 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Blue Owl Capital Holdings LP

Kulkarni Sandeep Chidambar

Robinson Ryan F.

Middlekauff W Bradford

Jones Susan Dana

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Investor Presentation

– Phase 2 TRANQUILITY Trial Surpasses Enrollment Target, With 143 Total Patients Enrolled; Topline Data Expected in Second Quarter of 2025 –

Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

SEC STAFF LETTER